Human Anti-Human CXCR4 Recombinant Antibody (TAB-H72) (CAT#: TAB-H72)

Recombinant human antibody to Human CXCR4

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-Human CXCR4 Recombinant Antibody (TAB-H72) in SDS-PAGE

Figure 1 Anti-Human CXCR4 Recombinant Antibody (TAB-H72) in SDS-PAGE

SDS-PAGE analysis of TAB-H72 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.

SEC-HPLC

Figure 2 Anti-Human CXCR4 Recombinant Antibody (TAB-H72) in HPLC

Figure 2 Anti-Human CXCR4 Recombinant Antibody (TAB-H72) in HPLC

The purity of TAB-H72 was greater than 95% as determined by SEC-HPLC.


Specifications

  • Host Species
  • human
  • Derivation
  • human
  • Type
  • IgG4 - kappa
  • Specificity
  • CXCR4(chemokine (C-X-C motif) receptor 4, fusin, stromal cell-derived factor 1 receptor, SDF-1 receptor, CXCL12 receptor, CD184) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA, ICC
  • MW
  • 146.2 kDa
  • Related Disease
  • Acute myeloid leukemia (AML)

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.

Applications

  • Application Notes
  • The CXCR4 antibody has been reported in applications of FC, Cyt, WB, IHC, RT-PCR, IF, MTT.
    WB: Cells were harvested and lysed using lysis buffer supplemented with 5 mM NaF, 2 mM Na3VO4, 1 mM PMSF (polymethylsulfonylfluoride), 5 mg/ml leupeptin, and 5 mg/ml aprotinin.
    IHC: Autopsy specimens of synchronous secondary extramedullary MM sites wereanalyzed for the expression of CD138 and CXCR4. Murine BM tissues (femurs)were analyzed for the expression of human CD138 and stained with hema-toxylin-eosin.

Target

  • Alternative Names
  • FB22; HM89; LAP3; LCR1; NPYR; WHIM; CD184; LAP-3; LESTR; NPY3R; NPYRL; WHIMS; HSY3RR; NPYY3R; WHIMS1; D2S201E

Related Resources

  • Biosimilar Overview
Please refer to Ulocuplumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ulocuplumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CXCR4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Mouse Antibody Products Humanized Antibody Products Human Antibody Products Chicken IgY Antibody Products Neutralizing Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products ScFv Antibody Products IgG Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads ScFv-Fc Chimera Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-H72. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-H72, RRID: AB_3112044)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare